Patent · US Active

Antibodies against cancer antigen TMEFF2 and uses thereof

US7674883B2 · kind B2 · utility

3Cited by

1References

14Claims

0Family size

Assignee

Facet Biotech Corporation · US

Inventors

Vinay Bhaskar · South San Francisco, US
Agustin de la Calle · Planegg, DE
Debbie Law · San Francisco, US
Ingrid Caras · San Francisco, US
Vanitha Ramakrishnan · Belmont, US
Richard Murray · Pasadena, US
Daniel Afar · Santa Monica, US
David Powers · Fairfax, US

Key dates

Filing date	Sep 13, 2007
Grant date	Mar 9, 2010
Priority date	—
Expiry date	Sep 13, 2027

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/77
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Described herein are methods and compositions that can be used for diagnosis and treatment of cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.